Maurice Karrenbrock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maurice Karrenbrock has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Luigi Gervasio
School of Pharmaceutical Sciences, University of Geneva, Geneva 1206, Switzerland
5 shared publications - Piero Procacci
Dipartimento di Chimica “Ugo Schiff”, Università degli Studi di Firenze, Via della Lastruccia 3, 50019 Sesto Fiorentino, Italy
3 shared publications - Valerio Rizzi
School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, CH-1206 Geneva, CH, Switzerland
3 shared publications - Alberto Borsatto
School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, CH-1206 Geneva, CH
2 shared publications Marco Pagliai
2 shared publications- Marina Macchiagodena
Università degli studi di Firenze
2 shared publications
Latest Publications
- Open Access
- 20 September 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry Letters
- Vol. 15 (39) , 9871-9880
Absolute Binding Free Energies with OneOPES
The calculation of absolute binding free energies (ABFEs) for protein-ligand systems has long been a challenge. Recently, refined force fields and algorithms have improved the quality of the ABFE calculations. However, achieving the level of accuracy required to inform drug discovery efforts remains difficult. Here, we present a transferable enhanced sampling strategy to accurately calculate absolute binding free energies using OneOPES with simple geometric collective variables. We tested the strategy on two protein targets, BRD4 and Hsp90, complexed with a total of 17 chemically diverse ligands, including both molecular fragments and drug-like molecules. Our results show that OneOPES accurately predicts protein-ligand binding affinities with a mean unsigned error within 1 kcal mol-1 of experimentally determined free energies, without the need to tailor the collective variables to each system. Furthermore, our strategy effectively samples different ligand binding modes and consistently matches the experimentally determined structures regardless of the initial protein-ligand configuration. Our results suggest that the proposed OneOPES strategy can be used to inform lead optimization campaigns in drug discovery and to study protein-ligand binding and unbinding mechanisms.
- 20 September 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry Letters
- Vol. 15 (39) , 9871-9880
Open AccessAbsolute Binding Free Energies with OneOPES
The calculation of absolute binding free energies (ABFEs) for protein-ligand systems has long been a challenge. Recently, refined force fields and algorithms have improved the quality of the ABFE calculations. However, achieving the level of accuracy required to inform drug discovery efforts remains difficult. Here, we present a transferable enhanced sampling strategy to accurately calculate absolute binding free energies using OneOPES with simple geometric collective variables. We tested the strategy on two protein targets, BRD4 and Hsp90, complexed with a total of 17 chemically diverse ligands, including both molecular fragments and drug-like molecules. Our results show that OneOPES accurately predicts protein-ligand binding affinities with a mean unsigned error within 1 kcal mol-1 of experimentally determined free energies, without the need to tailor the collective variables to each system. Furthermore, our strategy effectively samples different ligand binding modes and consistently matches the experimentally determined structures regardless of the initial protein-ligand configuration. Our results suggest that the proposed OneOPES strategy can be used to inform lead optimization campaigns in drug discovery and to study protein-ligand binding and unbinding mechanisms.
- Open Access
- 1 August 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Absolute Binding Free Energies with OneOPES
The calculation of absolute binding free energies (ABFEs) for protein-ligand systems has long been a challenge. Recently, refined force fields and algorithms have improved the quality of ABFE calculations. However, achieving the level of accuracy required to inform drug discovery efforts remains difficult. Here, we present a transferable enhanced sampling strategy to accurately calculate absolute binding free energies using OneOPES with simple geometric collective variables. We tested the strategy on two protein targets, BRD4 and Hsp90, complexed with a total of 17 chemically diverse ligands, including both molecular fragments and drug-like molecules. Our results show that OneOPES accurately predicts protein–ligand binding affinities with a mean unsigned error within 1 kcal mol-1 of experimentally determined free energies, without the need to tailor the collective variables to each system. Furthermore, our strategy effectively samples different ligand binding modes, and consistently matches the experimentally determined structures regardless of the initial protein-ligand configuration. Our results suggest that the proposed OneOPES strategy can be used to inform lead optimization campaigns in drug discovery and to study protein-ligand binding and unbinding mechanisms.
- 1 August 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAbsolute Binding Free Energies with OneOPES
The calculation of absolute binding free energies (ABFEs) for protein-ligand systems has long been a challenge. Recently, refined force fields and algorithms have improved the quality of ABFE calculations. However, achieving the level of accuracy required to inform drug discovery efforts remains difficult. Here, we present a transferable enhanced sampling strategy to accurately calculate absolute binding free energies using OneOPES with simple geometric collective variables. We tested the strategy on two protein targets, BRD4 and Hsp90, complexed with a total of 17 chemically diverse ligands, including both molecular fragments and drug-like molecules. Our results show that OneOPES accurately predicts protein–ligand binding affinities with a mean unsigned error within 1 kcal mol-1 of experimentally determined free energies, without the need to tailor the collective variables to each system. Furthermore, our strategy effectively samples different ligand binding modes, and consistently matches the experimentally determined structures regardless of the initial protein-ligand configuration. Our results suggest that the proposed OneOPES strategy can be used to inform lead optimization campaigns in drug discovery and to study protein-ligand binding and unbinding mechanisms.
- 7 February 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 128 (7) , 1595-1605
Addressing Suboptimal Poses in Nonequilibrium Alchemical Calculations
Alchemical transformations can be used to quantitatively estimate absolute binding free energies at a reasonable computational cost. However, most of the approaches currently in use require knowledge of the correct (crystallographic) pose. In this paper, we present a combined Hamiltonian replica exchange nonequilibrium alchemical method that allows us to reliably calculate absolute binding free energies, even when starting from suboptimal initial binding poses. Performing a preliminary Hamiltonian replica exchange enhances the sampling of slow degrees of freedom of the ligand and the target, allowing the system to populate the correct binding pose when starting from an approximate docking pose. We apply the method on 6 ligands of the first bromodomain of the BRD4 bromodomain-containing protein. For each ligand, we start nonequilibrium alchemical transformations from both the crystallographic pose and the top-scoring docked pose that are often significantly different. We show that the method produces statistically equivalent binding free energies, making it a useful tool for computational drug discovery pipelines.
- 7 February 2024
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 128 (7) , 1595-1605
Addressing Suboptimal Poses in Nonequilibrium Alchemical Calculations
Alchemical transformations can be used to quantitatively estimate absolute binding free energies at a reasonable computational cost. However, most of the approaches currently in use require knowledge of the correct (crystallographic) pose. In this paper, we present a combined Hamiltonian replica exchange nonequilibrium alchemical method that allows us to reliably calculate absolute binding free energies, even when starting from suboptimal initial binding poses. Performing a preliminary Hamiltonian replica exchange enhances the sampling of slow degrees of freedom of the ligand and the target, allowing the system to populate the correct binding pose when starting from an approximate docking pose. We apply the method on 6 ligands of the first bromodomain of the BRD4 bromodomain-containing protein. For each ligand, we start nonequilibrium alchemical transformations from both the crystallographic pose and the top-scoring docked pose that are often significantly different. We show that the method produces statistically equivalent binding free energies, making it a useful tool for computational drug discovery pipelines.
- Open Access
- 2 October 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Addressing sub-optimal poses in non-equilibrium alchemical calculations
Alchemical transformations can be used to quantitatively estimate absolute binding free energies at reasonable computational cost. However, most of the approaches currently in use require knowledge of the correct (crystallographic) bond position. In this paper we present a combined Hamiltonian replica exchange non-equilibrium alchemical method that allows to reliably calculate absolute binding free energies, even when starting from sub-optimal initial binding poses. Performing a preliminary Hamiltonian replica exchange enhances the sampling of slow degrees of freedom of the ligand and the target allowing the system to populate the correct binding pose when starting from an approximate docking pose. We apply the method on 6 ligands of the first bromodomain of the BRD4 bromodomain containing protein. For each ligand, we start non-equilibrium alchemical transformations from both the crystallographic pose and the top-scoring docked pose that are often significantly different. We show that the method produces statistically equivalent binding free energies making it a useful tool for computational drug discovery pipelines.
- 2 October 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAddressing sub-optimal poses in non-equilibrium alchemical calculations
Alchemical transformations can be used to quantitatively estimate absolute binding free energies at reasonable computational cost. However, most of the approaches currently in use require knowledge of the correct (crystallographic) bond position. In this paper we present a combined Hamiltonian replica exchange non-equilibrium alchemical method that allows to reliably calculate absolute binding free energies, even when starting from sub-optimal initial binding poses. Performing a preliminary Hamiltonian replica exchange enhances the sampling of slow degrees of freedom of the ligand and the target allowing the system to populate the correct binding pose when starting from an approximate docking pose. We apply the method on 6 ligands of the first bromodomain of the BRD4 bromodomain containing protein. For each ligand, we start non-equilibrium alchemical transformations from both the crystallographic pose and the top-scoring docked pose that are often significantly different. We show that the method produces statistically equivalent binding free energies making it a useful tool for computational drug discovery pipelines.
- Open Access
- 28 February 2023
- Published by American Chemical Society (ACS) in ChemRxiv
A nonequilibrium alchemical method for drug-receptor absolute binding free energy calculations: the role of restraints
In this paper we further develop a combined Hamiltonian replica exchange / non-equilibrium alchemical method for absolute binding free energies and test its performance on 11 ligands of the BRD4 bromodomain protein. We compare the results obtained with our approach with those obtained with other equilibrium and non-equilibrium alchemical methods showing their relative strengths, weaknesses, and limits. We show how using an enhanced sampling technique, before the alchemical transformations, allows to get accurate estimates of the binding free energies even when starting with sub-optimal initial binding poses (e.g. from docking). We also study the effect of different restraining mechanisms on the final result, and introduce a new "Loose-Tight" restraining algorithm. The method proves to strike a good balance between ease of use, automation, speed, and accuracy for absolute ligand binding free energy calculations and our scripts make it easy to integrate it into pre-existing computational drug discovery pipelines.
- 28 February 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA nonequilibrium alchemical method for drug-receptor absolute binding free energy calculations: the role of restraints
In this paper we further develop a combined Hamiltonian replica exchange / non-equilibrium alchemical method for absolute binding free energies and test its performance on 11 ligands of the BRD4 bromodomain protein. We compare the results obtained with our approach with those obtained with other equilibrium and non-equilibrium alchemical methods showing their relative strengths, weaknesses, and limits. We show how using an enhanced sampling technique, before the alchemical transformations, allows to get accurate estimates of the binding free energies even when starting with sub-optimal initial binding poses (e.g. from docking). We also study the effect of different restraining mechanisms on the final result, and introduce a new "Loose-Tight" restraining algorithm. The method proves to strike a good balance between ease of use, automation, speed, and accuracy for absolute ligand binding free energy calculations and our scripts make it easy to integrate it into pre-existing computational drug discovery pipelines.
- Open Access
- 27 July 2021
Virtual Double-System Single-Box for Absolute Dissociation Free Energy Calculations in GROMACS
- 27 July 2021
Open AccessVirtual Double-System Single-Box for Absolute Dissociation Free Energy Calculations in GROMACS
- Open Access
- 27 July 2021
Virtual Double-System Single-Box for Absolute Dissociation Free Energy Calculations in GROMACS
- 27 July 2021
Open AccessVirtual Double-System Single-Box for Absolute Dissociation Free Energy Calculations in GROMACS